FMT in Triple Negative Breast Cancer Guided by ctDNA
Clinical trial NCT07292142 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07292142
- Sponsor
- Jewish General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2029-12-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.